|
|
|
Insider
Information: |
Evnin Anthony B |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
12 |
|
Direct
Shares |
256,515 |
|
Indirect Shares
|
17,979,070 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$641,597,267 |
|
|
Total
Shares |
18,235,585 |
|
|
Total
Value |
$641,597,267 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
118.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Renovis Inc |
RNVS |
Director |
2008-05-02 |
0 |
2008-05-02 |
0 |
Premium* |
|
OTIX GLOBAL INC |
OTIX |
Director |
2004-03-11 |
33,202 |
2004-03-11 |
0 |
Premium* |
|
Icagen Inc |
ICGN |
Director |
2011-09-02 |
7,910 |
2011-09-02 |
0 |
Premium* |
|
Coley Pharmaceutical Group, Inc. |
COLY |
Director, 10% Owner |
2005-08-15 |
0 |
2005-08-15 |
50,439 |
Premium* |
|
Viracta Therapeutics Ord Shs |
VIRX |
Director |
2005-09-30 |
0 |
2005-09-30 |
24,409 |
Premium* |
|
Infinity Pharmaceuticals Inc |
INFI |
|
2022-06-16 |
215,403 |
2014-09-30 |
0 |
Premium* |
|
Pharmos Corp |
PARS |
Director, 10% Owner |
2006-10-25 |
0 |
2009-05-08 |
9,665,196 |
Premium* |
|
Aveo Pharmaceuticals Inc |
AVEO |
Director |
2023-01-19 |
0 |
2018-11-21 |
109 |
Premium* |
|
Acceleron Pharma Inc |
XLRN |
Director |
|
0 |
2013-09-24 |
2,496,152 |
Premium* |
|
Juno Therapeutics, Inc. |
JUNO |
Director |
2018-02-14 |
0 |
2015-07-27 |
0 |
Premium* |
|
Cantel Medical Corp |
CMN |
Director |
2021-06-02 |
0 |
2017-01-05 |
0 |
Premium* |
|
Constellation Pharmaceuticals Inc |
CNST |
Director |
2018-07-23 |
0 |
2019-12-13 |
5,742,765 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CNST |
Constellation Pharmaceuti... |
Director |
|
2019-10-03 |
4 |
B |
$8.50 |
$23,999,997 |
I/I |
2,823,529 |
5,342,765 |
2.1 |
- |
|
JUNO |
Juno Therapeutics, Inc. |
Director |
|
2015-06-17 |
4 |
AS |
$51.59 |
$15,914,906 |
I/I |
(300,000) |
1,449,999 |
0 |
- |
|
JUNO |
Juno Therapeutics, Inc. |
Director |
|
2015-06-18 |
4 |
AS |
$52.07 |
$14,932,567 |
I/I |
(283,333) |
1,166,666 |
0 |
- |
|
JUNO |
Juno Therapeutics, Inc. |
Director |
|
2015-06-25 |
4 |
AS |
$48.39 |
$14,739,506 |
I/I |
(300,000) |
866,666 |
0 |
- |
|
CNST |
Constellation Pharmaceuti... |
Director |
|
2019-12-13 |
4 |
B |
$34.50 |
$13,800,000 |
I/I |
400,000 |
5,742,765 |
2.1 |
- |
|
JUNO |
Juno Therapeutics, Inc. |
Director |
|
2015-06-26 |
4 |
AS |
$46.57 |
$13,325,976 |
I/I |
(283,333) |
583,333 |
0 |
- |
|
JUNO |
Juno Therapeutics, Inc. |
Director |
|
2015-07-27 |
4 |
AS |
$47.82 |
$10,907,594 |
I/I |
(227,354) |
0 |
0 |
- |
|
INFI |
Infinity Pharmaceuticals ... |
Director |
|
2013-11-26 |
4 |
S |
$14.72 |
$2,045,506 |
I/I |
(138,961) |
131,407 |
0 |
- |
|
ICGN |
Icagen Inc |
Director |
|
2011-09-02 |
4 |
D |
$6.00 |
$2,043,300 |
I/I |
(340,550) |
0 |
0 |
- |
|
CNST |
Constellation Pharmaceuti... |
Director |
|
2018-07-23 |
4 |
B |
$15.00 |
$2,000,010 |
I/I |
133,334 |
2,519,236 |
2.25 |
- |
|
INFI |
Infinity Pharmaceuticals ... |
Director |
|
2014-09-30 |
4 |
S |
$13.56 |
$1,525,229 |
I/I |
(112,451) |
0 |
0 |
- |
|
ICGN |
Icagen Inc |
Director |
|
2007-02-06 |
4 |
B |
$1.38 |
$1,453,905 |
I/I |
1,053,554 |
1,587,593 |
2.1 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
Director |
|
2018-11-15 |
4 |
S |
$1.86 |
$1,248,265 |
I/I |
(670,894) |
151,035 |
0 |
- |
|
CMN |
Cantel Medical Corp |
Director |
|
2021-06-02 |
4 |
D |
$80.59 |
$977,718 |
D/D |
(12,132) |
0 |
0 |
- |
|
VIRX |
Viracta Therapeutics Ord ... |
Director |
|
2005-09-30 |
4 |
B |
$7.00 |
$945,000 |
I/I |
135,000 |
649,955 |
2.1 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
Director |
|
2023-01-19 |
4 |
D |
$15.00 |
$627,615 |
D/D |
(41,841) |
0 |
0 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
Director |
|
2018-11-14 |
4 |
S |
$1.90 |
$617,862 |
I/I |
(325,139) |
821,929 |
0 |
- |
|
INFI |
Infinity Pharmaceuticals ... |
Director |
|
2012-11-27 |
4 |
S |
$25.28 |
$446,171 |
I/I |
(17,648) |
298,903 |
0 |
- |
|
INFI |
Infinity Pharmaceuticals ... |
Director |
|
2012-11-27 |
4 |
OE |
$5.63 |
$407,724 |
D/D |
58,657 |
59,580 |
0 |
- |
|
INFI |
Infinity Pharmaceuticals ... |
Director |
|
2013-11-25 |
4 |
S |
$15.40 |
$365,026 |
I/I |
(23,703) |
270,368 |
0 |
- |
|
INFI |
Infinity Pharmaceuticals ... |
Director |
|
2014-10-03 |
4 |
OE |
$11.85 |
$307,765 |
D/D |
24,500 |
91,900 |
0 |
- |
|
JUNO |
Juno Therapeutics, Inc. |
Director |
|
2016-03-28 |
4 |
B |
$36.22 |
$292,662 |
D/D |
8,000 |
58,000 |
2.39 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
Director |
|
2018-11-16 |
4 |
S |
$1.82 |
$274,400 |
I/I |
(151,035) |
0 |
0 |
- |
|
INFI |
Infinity Pharmaceuticals ... |
Director |
|
2013-12-02 |
4 |
S |
$14.56 |
$258,527 |
I/I |
(17,756) |
112,451 |
0 |
- |
|
JUNO |
Juno Therapeutics, Inc. |
Director |
|
2017-06-20 |
4 |
B |
$24.40 |
$219,600 |
D/D |
9,000 |
66,301 |
2.39 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|